DK3010539T3 - METHODS OF TREATING NASAL POLYPOSIS BY ADMINISTRATING AN IL-4R ANTAGONIST - Google Patents
METHODS OF TREATING NASAL POLYPOSIS BY ADMINISTRATING AN IL-4R ANTAGONISTInfo
- Publication number
- DK3010539T3 DK3010539T3 DK14742021.0T DK14742021T DK3010539T3 DK 3010539 T3 DK3010539 T3 DK 3010539T3 DK 14742021 T DK14742021 T DK 14742021T DK 3010539 T3 DK3010539 T3 DK 3010539T3
- Authority
- DK
- Denmark
- Prior art keywords
- administrating
- antagonist
- methods
- nasal polyposis
- treating nasal
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361837912P | 2013-06-21 | 2013-06-21 | |
| EP14305670 | 2014-05-07 | ||
| PCT/US2014/043440 WO2014205365A1 (en) | 2013-06-21 | 2014-06-20 | Methods for treating nasal polyposis by administering an il-4r antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3010539T3 true DK3010539T3 (en) | 2019-10-21 |
Family
ID=66440559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14742021.0T DK3010539T3 (en) | 2013-06-21 | 2014-06-20 | METHODS OF TREATING NASAL POLYPOSIS BY ADMINISTRATING AN IL-4R ANTAGONIST |
Country Status (10)
| Country | Link |
|---|---|
| JP (3) | JP6640977B2 (en) |
| DK (1) | DK3010539T3 (en) |
| ES (1) | ES2747630T3 (en) |
| HR (1) | HRP20191709T1 (en) |
| HU (1) | HUE046410T2 (en) |
| LT (1) | LT3010539T (en) |
| NZ (1) | NZ631118A (en) |
| PT (1) | PT3010539T (en) |
| SG (1) | SG10201912898XA (en) |
| TW (1) | TWI707694B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| EP2414520A2 (en) * | 2009-03-31 | 2012-02-08 | Altair Therapeutics, Inc. | Methods of modulating an immune response to a viral infection |
| UA111731C2 (en) * | 2010-10-06 | 2016-06-10 | Рідженерон Фармасьютікалз, Інк. | STABILIZED COMPOSITION CONTAINING ANTIBODY TO INTERLAYKIN-4 (IL-4R) RECEPTOR, OPTIONS |
| TWI709411B (en) * | 2013-06-21 | 2020-11-11 | 法商賽諾菲生物技術公司 | Use of an il-4r antagonist for the manufacture of a medicament for treating nasal polyposis |
-
2014
- 2014-06-20 SG SG10201912898XA patent/SG10201912898XA/en unknown
- 2014-06-20 PT PT147420210T patent/PT3010539T/en unknown
- 2014-06-20 NZ NZ631118A patent/NZ631118A/en unknown
- 2014-06-20 LT LTEP14742021.0T patent/LT3010539T/en unknown
- 2014-06-20 DK DK14742021.0T patent/DK3010539T3/en active
- 2014-06-20 HU HUE14742021A patent/HUE046410T2/en unknown
- 2014-06-20 ES ES14742021T patent/ES2747630T3/en active Active
- 2014-06-20 TW TW108101935A patent/TWI707694B/en active
-
2018
- 2018-12-27 JP JP2018243929A patent/JP6640977B2/en active Active
-
2019
- 2019-09-19 HR HRP20191709 patent/HRP20191709T1/en unknown
- 2019-12-25 JP JP2019233649A patent/JP6898421B2/en active Active
-
2021
- 2021-06-09 JP JP2021096260A patent/JP2021138743A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6898421B2 (en) | 2021-07-07 |
| TW201940193A (en) | 2019-10-16 |
| JP2021138743A (en) | 2021-09-16 |
| NZ752224A (en) | 2020-11-27 |
| JP2019069987A (en) | 2019-05-09 |
| LT3010539T (en) | 2019-10-10 |
| ES2747630T3 (en) | 2020-03-11 |
| JP6640977B2 (en) | 2020-02-05 |
| HRP20191709T1 (en) | 2019-12-13 |
| SG10201912898XA (en) | 2020-02-27 |
| JP2020073525A (en) | 2020-05-14 |
| NZ631118A (en) | 2019-05-31 |
| HUE046410T2 (en) | 2020-03-30 |
| PT3010539T (en) | 2019-10-14 |
| TWI707694B (en) | 2020-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1222567A1 (en) | Methods for treating nasal polyposis by administering an il-4r antagonist il-4r | |
| DK3004166T3 (en) | PROCEDURES FOR IMPROVING ALLERGEN-SPECIFIC IMMUNITY THERAPY BY ADMINISTRATION OF AN IL-4R INHIBITOR | |
| DK3139986T3 (en) | SYSTEM FOR ADMINISTRATING THERAPEUTIC GAS | |
| DK2958900T3 (en) | 2-AMINOPYRIMIDIN DERIVATIVES FOR TREATMENT OF VIRUS INFECTIONS | |
| DK2968071T3 (en) | UNIT FOR ORAL DELIVERY OF THERAPEUTIC COMPOUNDS | |
| DK3302565T3 (en) | FIXED DOSAGE FORMS OF PALBOCICLIB | |
| DK3023100T3 (en) | ANTITUM MEDICINE FOR INTERMITTING ADMINISTRATION OF FGFR HARMFUL | |
| DK2970493T3 (en) | PROCEDURES FOR RETIRING THERAPEUTIC EFFICIENT DOSAGE OF ANTI-CD47 MEANS | |
| DK3244948T3 (en) | DETERMINATION OF MEDICINE DOSAGE | |
| DK3080100T3 (en) | INHIBITORS OF LYSINE-SPECIFIC DEMETHYLASE-1 | |
| DK3003309T3 (en) | Treatment of cancer with PI3 kinase isoform modulators | |
| DK2964315T3 (en) | SYSTEM FOR TREATMENT OF NEUROMOTORICAL DYSFUNCTION | |
| DK3003075T3 (en) | Kit for inhaling vaporized substances | |
| BR112016009485A2 (en) | DRUG INHALER | |
| DK2968208T3 (en) | TREATMENT OF CATAPLEXIA | |
| DK2968221T3 (en) | PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE | |
| DK2981255T3 (en) | Therapeutic uses of empagliflozin | |
| DK3421468T3 (en) | Methods for preparing inhibitors of influenza virus replication | |
| DK3049117T3 (en) | Ultrasound-mediated delivery of drugs | |
| DK2948148T3 (en) | METHODS FOR TREATMENT OF AUTOIMMUNE, RESPIRATORY AND INFLAMMATORY DISORDERS BY INHALATION OF ROFLUMILAST N-OXIDE | |
| DK3068776T3 (en) | INHIBITORS OF REPLICATION OF INFLUENZAVIRA | |
| DK2948134T3 (en) | COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION OF MTOR INHIBITORS | |
| DK3035885T3 (en) | INHALER | |
| DK2961378T3 (en) | METHODS OF TREATING MITOCHONDRIC DISEASE | |
| DK2777689T3 (en) | New pharmaceutical composition for the treatment of fungal infections |